Skip to main content

Table 1 Characteristic of included studies prevalence of Dupuytren

From: The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis

Author, year, reference

Age (years)

Country

Sample size total

Sample size male

Sample size female

Prevalence %

Population

Asia

 Agrawal et al., 2014, [17]

3783 ≤ 50, 1949 ≥ 50

India

5732

2516

3216

7.2

Diabetic population

 Kiani et al., 2014, [18]

54.0 ± 13.2 Fe, 51.6 ± 16.5 Ma

Iran

432

134

298

7.4

Diabetic population

 Al-Matubsi et al., 2011, [19]

51.82 ± 11.68

Jordan

187

77

110

17.6

Diabetic population

 Lee et al., 2018, [20]

54 men, 49.5 women (mean)

South Korea

16630

-

-

3.2

General population

 Rajendran et al. (1), 2010, [21]

53.8 ± 8.2

India

206

98

108

84.0

Diabetic population

 Rajendran et al. (2), 2010, [21]

52.4 ± 8.3

India

203

106

97

58.6

General population

 Tajica et al., 2014, [22]

66.7 (40–92)

Japan

401

163

238

7.0

General population

 Yeh et al., 2015, [23]

60.7 ± 18.4 (men), 53.7 ± 15.5 (women)

China

1078

681

397

8.9

General population

 Pandey et al. (1), 2013, [24]

51.8 ± 11.5 (19–65)

India

200

102

98

19.0

Diabetic population

 Pandey et al. (2), 2013, [24]

53.1 ± 12.5 (19–65)

India

200

99

101

6.0

General population

Europe

 Degreef et al., 2010, [25]

≥ 50

Belgium

500

265

235

31.6

General population

 Gumundsson et al., 1999, [26]

46–74

Norway

1297

1297

0

19.2

General population

 Nordenskjöld et al., 2017, [27]

Over 20

Sweden

1300000

5208

1299

0.5

General population

 Wijnen et al., 2017, [28]

Born between 1900 and 1999

Belgium

215251

451

274

0.3

General population

 Arafa et al. (1), 1984, [29]

Over 30

England

392

131

261

6.4

Rheumatoid arthritis

 Arafa et al. (2), 1984, [29]

Over 30

England

555

254

301

16.0

General population

 Arafa et al. (3), 1991, [30]

Over 30

England

342

177

165

12.0

David Lewis Center Of Epilepsy Patient

 Arafa et al. (4), 1991, [30]

Over 30

England

373

241

132

37.8

Chalfont Center Of Epilepsy Patient

 Arkkila et al., 1996, [31]

33.2 ± 9.9 type I; 61.1 ± 12.4 type II

Finland

425

200

225

13.9

Diabetic population

 Arkkila et al., 2000, [32]

43.4 ± 9.5

Finland

28

28

0

32.1

Diabetes type I

 Attali et al. (1), 1987, [33]

54 ± 18

France

432

246

186

28

Different groups which are named

 Attali et al. (2), 1987, [33]

58.9 ± 22.7

France

174

77

97

12.6

General population

 Bergenudd et al., 1993, [34]

55 years old

Sweden

574

255

319

6.3

Light, moderate and heavy physical workers

 French et al., 1990, [35]

23–56

England

50

50

0

6.0

Patients with HIV

 Bennett (1), 1982, [36]

15–64

UK

216

216

0

7.4

Manual workers in bagging and packing plant

 Bennett (2), 1982, [36]

15–64

UK

84

84

0

1.2

Workers in no bagging or packing

 Broekstra et al. (1), 2016, [37]

65–71

Netherlands

169

169

0

51.5

Hockey players aged over 60 years

 Broekstra et al. (2), 2016, [37]

59–71

Netherlands

156

156

0

13.5

General population

 Burke et al., 2005, [38]

25–99

UK

97537

97537

0

8.1

Miners

 Descatha et al., 2012,

20–59

France

2161

2161

0

1.2

Manual workers

 Descatha et al., 2013, [39]

59–73

France

13587

3570

1017

7.4

General population

 Edington et al. (1), 1991, [40]

62 ± 9

UK

200

124

76

23.5

Diabetic population

 Edington et al. (2), 1991, [40]

58 ± 6

UK

170

103

67

24.7

General population

 Finsen et al., 2001, [41]

Over 50

Norway

456

261

195

7.7

General population

 Gamstedt et al., 1993, [42]

19–62 (mean 42)

Sweden

99

49

50

16.2

Diabetic population

 Kristján et al., 2000, [43]

Over 45

Iceland

2165

1297

868

13.3

General population

 Carson et al., 1993, [44]

65 to 97 (mean 76.2)

UK

400

400

0

13.8

Ex-military service pensioners

 Khan et al., 2004, [45]

Over 40

England and Wales

502493

502493

0

0.03

General population

 Kovacs et al. (1), 2012, [46]

52.46 ± 13.56

Romania

187

93

94

26.7

Diabetic population

 Kovacs et al. (2), 2012, [46]

51.19 ± 16.21

Romania

197

97

100

5.6

General population

 Lanting et al., 2013,

50–89

Netherlands

763

348

415

22.1

General population

 Lennox et al., 1993, [47]

Over 60

Scotland

200

100

100

30.0

Consecutive geriatric patients

 Noble et al. (1), 1992, [48]

Over 30

England

100

  

28.0

Alcoholic patients

 Noble et al. (2), 1992, [48]

Over 30

England

82

  

22.0

Hepatic non-alcoholic patient

 Noble et al. (3), 1992, [48]

Over 30

England

100

  

8.0

General population

 Palmer et al., 2015, [49]

16–64

UK

4969

4969

0

1.4

General population

 Patri et al., 1986, [50]

20–90

France

155

76

79

9.0

General population

 Ramchurn et al., 2009, [51]

55

UK

96

60

36

12.5

Diabetic population

 Thomas and Clarke, 1992, [52]

25–85

UK

500

499

1

13.6

General population

 Caffiniire et al., 1983, [53]

20–65

France

5206

5206

0

3.8

Iron workers

 Zerajic and Finsen, 2004, [54]

Over 50

Bosnia and Herzegovina

1207

610

597

25.2

General population

 Bulfoni (1), 1980, [55]

-

Italy

125

-

-

72.0

Alcoholic cirrhosis

 Bulfoni (2), 1980, [55]

-

Italy

185

-

-

37.8

Hepatic alcoholic involvement without cirrhosis

 Bulfoni (3), 1980, [55]

-

Italy

163

-

-

23.9

Alcoholism without hepatic involvement

 Diris et al., 2003, [56]

-

France

100

-

-

7.0

Diabetic population

 Renard et al. (1), 1994, [57]

-

France

60

  

35.0

Diabetic type I

 Renard et al. (2), 1994, [57]

-

France

60

  

30.0

Diabetic type II

 Renard et al. (3), 1994, [57]

-

France

120

  

6.7

General population

 Stradner et al., 1987, [58]

-

UK

100

  

42.0

Diabetic population

 Trybus et al., 2012, [59]

-

Poland

101

  

14.9

General population

 Sari, 2013, [60]

51.14 ± 15.85

Turkey

21450

6477

14973

0.04

Physiotherapy and rehabilitation

 Ardic et al. (1), 2002, [61]

57.8 ± 11.9 (32–81)

Turkey

78

23

55

21.8

Diabetic population

 Ardic et al. (2), 2002, [61]

55.7 ± 11.5 (30–79)

Turkey

37

10

27

2.7

General population

 Aydeniz et al. (1), 2008, [62]

58.0 ± 9.1

Turkey

102

44

58

12.7

Diabetic population

 Aydeniz et al. (2), 2008, [62]

60.1 ± 7.6

Turkey

101

50

51

3.9

General population

 Cakir et al., 2003, [63]

46 ± 12 (20–76)

Turkey

137

26

11

8.8

Thyroid disease

Africa

 Beighton and Valkenburg, 1974, [64]

Over 35

South Africa

111

63

48

13.5

General population

 Mustafa et al., 2016, [65]

57.8 ± 9.5 (range 23–88)

South Africa

1000

478

522

18.6

Diabetic population

America

 Barton and Barton (1), 2012, [66]

48 ± 13 M/51 ± 14 W

USA

294

188

106

1.0

Hemochromatosis probands with HFE C282Y homozygosity

 Barton and Barton (2), 2012, [66]

48 ± 13 M/51 ± 15 W

USA

67

39

28

1.5

Hemochromatosis probands with C282y/H63d compound heterozygosity

 Dibenedetti et al., 2011, [67]

Over 18

USA

23103

11420

11683

2.0

General population

 Diep et al., 2015, [68]

Over 18

USA

827

353

474

37.0

Asymptomatic patients

 Robert et al., 1977, [69]

29–80 (mean 57)

USA

55

13

42

10.9

Rheumatoid arthritis

 Larkin et al., 2014, [70]

52.2 ± 6.9

USA

1217

633

584

8.6

Diabetes type I

 Patel et al., 2014, [71]

59.1 ± 12.90

USA

97

51

46

19.6

Patients with psoriasis

 Alesia et al., 1999, [72]

Over 25

USA

324300

  

0.3

General population

 Su et al. (1), 1972, [73]

-

USA

142

142

0

12.0

General population

 Su et al. (2), 1972, [73]

-

USA

130

130

0

19.2

Alcoholic without cirrhosis

 Su et al. (3), 1972, [73]

-

USA

133

133

0

18.0

Alcoholic with cirrhosis

 Weinstein et al. (1), 2011, [74]

Over 40

USA

220748

-

-

0.5

Hispanic population

 Weinstein et al. (2), 2011, [74]

Over 40

USA

137205

-

-

0.3

Black population

 Weinstein et al. (3), 2011, [74]

Over 40

USA

118909

-

-

0.3

White population

 Weinstein et al. (4), 2011, [74]

Over 40

USA

70058

-

-

0.3

Asian population

 Weinstein et al. (5), 2011, [74]

Over 40

USA

2055

-

-

0.3

Native American

 Weinstein et al. (6), 2011, [74]

Over 40

USA

607119

-

-

0.4

Other population